The Paris system in interstitial radiation therapy

Acta Radiologica: Oncology, Radiation, Physics, Biology
B PierquinD V Ash

Abstract

As a result of almost 20 years' experience using 192Ir wires in interstitial radiation therapy, a new method of dose calculation has been evolved, which is especially suitable for the techniques employed. Because this system was developed and brought into routine use in Paris, it was called the Paris System. Its basic principles are outlined in this report and the manner in which it is used in clinical practise is explained.

References

Jul 3, 1969·Annals of the New York Academy of Sciences·J Dutreix, A Dutreix
Jul 1, 1972·Clinical Radiology·C H Paine
Jun 1, 1970·Acta Radiologica: Therapy, Physics, Biology·M SchliengerB Pierquin
Apr 1, 1966·Acta Radiologica: Therapy, Physics, Biology·E J HallB J Shepstone

❮ Previous
Next ❯

Citations

Feb 20, 2009·International Journal of Clinical Oncology·Csaba Polgár, Tibor Major
Oct 1, 1988·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·J M PaulP C Philip
Feb 1, 1995·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·E TouboulJ Blondon
Jun 1, 1984·International Journal of Radiation Oncology, Biology, Physics·M T GillinJ D Cox
Jan 1, 1995·International Journal of Radiation Oncology, Biology, Physics·R D Zwicker, R Schmidt-Ullrich
Jun 26, 2004·Cancer radiothérapie : journal de la Société française de radiothérapie oncologique·D LerougeJ Blondon
Feb 13, 2001·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·B R PietersJ H Borger
Feb 7, 2002·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Tibor MajorGyörgy Németh
Jun 18, 2002·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Alexandra ReschWolfgang Seitz
Mar 1, 1997·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·E TouboulM Schlienger
Mar 30, 2000·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·T MajorG Németh
Aug 14, 2003·Cancer radiothérapie : journal de la Société française de radiothérapie oncologique·E Deniaud-AlexandreM Schlienger
Jan 1, 1997·International Journal of Radiation Oncology, Biology, Physics·F M WatermanN Suntharalingam
Mar 5, 1998·International Journal of Radiation Oncology, Biology, Physics·A P SandhuJ Paul
Feb 16, 1999·International Journal of Radiation Oncology, Biology, Physics·E TouboulM Housset
Jul 27, 1999·International Journal of Radiation Oncology, Biology, Physics·R D ZwickerR K Schmidt-Ullrich
Sep 7, 1999·International Journal of Radiation Oncology, Biology, Physics·C HennequinC Maylin
Oct 19, 1999·International Journal of Radiation Oncology, Biology, Physics·P KneschaurekR Wehrmann
Jul 22, 2008·Magyar onkologia·Zoltán Takácsi Nagy, Miklós Kásler
Mar 4, 2008·International Journal of Medical Sciences·Than S KehwarKamlesh Passi
Aug 1, 1997·Medical Physics·F BallesterF Lliso
Apr 18, 2002·International Journal of Radiation Oncology, Biology, Physics·Jan F EvensenJohan E Tausjø
Oct 1, 1986·The British Journal of Radiology·C J KotreP J Dawes
Jan 1, 1995·The British Journal of Radiology·K A Langmack, S J Thomas
Apr 17, 2014·The British Journal of Radiology·C D Lee
Jan 1, 1989·The British Journal of Radiology·M HoshinaM Takeda
Sep 1, 1993·The British Journal of Radiology·R D JonesR Thomas
Jan 1, 1982·Acta Radiologica. Oncology·J W DenhamM H Bennett
Jan 1, 1983·Acta Radiologica. Oncology·A D WelshJ B Stedeford
Jan 1, 1983·Acta Radiologica. Oncology·A DutreixC H Paine
Jan 1, 1996·Acta Oncologica·J F EvensenJ E Tausjø
Jan 1, 1993·Acta Oncologica·T W LeungD K Chan
Jan 1, 1980·International Journal of Radiation Oncology, Biology, Physics·B PierquinS Hannoun
Jan 1, 1991·International Journal of Radiation Oncology, Biology, Physics·C B Saw, N Suntharalingam
Feb 15, 1993·International Journal of Radiation Oncology, Biology, Physics·C B Saw, A Wu
Aug 1, 1983·International Journal of Radiation Oncology, Biology, Physics·B L Pierquin
Dec 1, 1985·International Journal of Radiation Oncology, Biology, Physics·R D ZwickerB Schiller

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.